Key statistics
On Friday, SAGE Therapeutics Inc (SG7:BER) closed at 6.74, 3.09% above its 52-week low of 6.53, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.10 |
---|---|
High | 7.10 |
Low | 6.73 |
Bid | 6.27 |
Offer | 7.24 |
Previous close | 7.16 |
Average volume | 2.40 |
---|---|
Shares outstanding | 61.05m |
Free float | 53.79m |
P/E (TTM) | -- |
Market cap | 457.88m USD |
EPS (TTM) | -7.41 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 19:30 BST.
More ▼
Press releases
- Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
- Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor
- Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024